4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-18-060128
Chief Technology Officer sold 25,000 shares at $13.79 ($344,750)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Binder-Scholl Gwendolyn Knowlton Chief Technology Officer | 2018-10-01 | Sale | −25,000 | $13.79 | $344,750 | 0 | D |
| Open-market sales · 25,000 sh · avg $13.79 · $344,750 | |||||||
Loading xslF345X03/a4.xml…